Rainer Boehm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cellectis S A : Report of the board of directors to the Combined Shareholders Meeting - June 28, 2024

Cellectis S A : Report of the board of directors to the Combined Shareholders Meeting - June 28, 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

North carolinaUnited statesFrance generalAxel sven malkomesDavid sourdiveRainer boehmMarc dunoyerPierre bastidDonalda bergstromDonald bergstromInstitut pasteurLaurent arthaudJean pierre garnierEnyo pharmaCroix jarryFusion pharmaceuticals

Cellectis S A : Report of the board of directors to the combined shareholders meeting - June 27, 2023

CELLECTIS A corporation with a share capital of 2,779,188.40 euros Headquarters: 8, rue de la Croix Jarry - 75013 Paris . | June 1, 2023

France generalUnited statesPierre bastidLaurent arthaudDonald bergstromAxel sven malkomesCroix jarryInstitut pasteurDavid sourdiveRainer boehmJean pierre garnierAnnick schwebigNextvivo incCarrier global corpHumanigen incTribogenics inc

Cellectis S A : NOTICE OF MEETING COMBINED GENERAL MEETING OF SHAREHOLDERS - Form 6-K

NOTICE OF MEETING COMBINED GENERAL MEETING OF SHAREHOLDERS OF JUNE 27, 2023 The shareholders are hereby informed that. | May 23, 2023

France generalUnited statesRainer boehmPierre bastidCroix jarryCecile chartierJean pierre garnierLaurent arthaudCompany bylawsBylaws of the companyCompany on euronext growth parisCompanya financing agreementEuropean investment bankService assemblCommercial codeMrs cecile chartier

Omega Therapeutics Announces Appointment of Rainer Boehm to its Board of Directors

/PRNewswire/ Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to using.

Baden wübergUnited kingdomJason bracoRainer boehmKevin murphyMahesh karandeNoubar afeyanAffairs officerPrnewswire omega therapeutics incUniversity of ulmMaster of business administrationLifesci communicationsMaster of public healthHumanigen incSchiller universityFormer novartis veteran brings deep expertise

Nordic Nanovector ASA: Results for the First Quarter 2022

/PRNewswire/ Nordic Nanovector ASA (OSE: NANOV) announces its results for the first quarter 2022. A presentation by Nordic Nanovector s senior management.

United statesErik skullerudThomas ramdahlRainer boehmMalene brondbergFrazer hall mediAmerican association for cancer researchThon hotel vika atriumNordic nanovectorAmerican associationCancer researchScientific reportsNon executive directorsHotel vika atriumFrazer hallSecurities trading